Federico Innocenti

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 32

Top Topics

Hepatitis C Virus

Metastatic Colorectal Cancer

Gene Expression

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer research communications

The pharmacogenomics journal

British journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Julia Coelho França Quintanilha, William Kevin Kelly, Federico Innocenti
Contribution of plasma levels of VEGF-A and angiopoietin-2 in addition to a genetic variant in KCNAB1 to predict the risk of bevacizumab-induced hypertension. The pharmacogenomics journal 24 (4) (2024)
Spinel Karas, Ron H J Mathijssen, Ron H N van Schaik, Alan Forrest, Timothy Wiltshire, Robert R Bies, Federico Innocenti
Model-Based Prediction of Irinotecan-Induced Grade 4 Neutropenia in Cancer Patients: Influence of Incorporating Germline Genetic Factors in the Model. Clinical pharmacology and therapeutics 115 (5) (2024)
Francesca Battaglin, Fang-Shu Ou, Xueping Qu, Howard S Hochster, Donna Niedzwiecki, Richard M Goldberg, Robert J Mayer, Karam Ashouri, Tyler J Zemla, Charles D Blanke, Alan P Venook, Omar Kabbarah, Heinz-Josef Lenz, Federico Innocenti
HER2 Gene Expression Levels Are Predictive and Prognostic in Patients With Metastatic Colorectal Cancer Enrolled in CALGB/SWOG 80405. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (16) (2024)
Francesca Battaglin, Fang-Shu Ou, Xueping Qu, Howard S Hochster, Donna Niedzwiecki, Richard M Goldberg, Robert J Mayer, Karam Ashouri, Tyler J Zemla, Charles D Blanke, Alan P Venook, Omar Kabbarah, Heinz-Josef Lenz, Federico Innocenti
HER2 Gene Expression Levels Are Predictive and Prognostic in Patients With Metastatic Colorectal Cancer Enrolled in CALGB/SWOG 80405. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Julia Coelho França Quintanilha, William Kevin Kelly, Federico Innocenti
Contribution of plasma levels of VEGF-A and angiopoietin-2 in addition to a genetic variant in KCNAB1 to predict the risk of bevacizumab-induced hypertension. The pharmacogenomics journal 24 (4) (2024)
Julia Coelho França Quintanilha, William Kevin Kelly, Federico Innocenti
Contribution of plasma levels of VEGF-A and angiopoietin-2 in addition to a genetic variant in KCNAB1 to predict the risk of bevacizumab-induced hypertension. The pharmacogenomics journal 24 (4) (2024)
Ghassan K Abou-Alfa, Susan M Geyer, Andrew B Nixon, Federico Innocenti, Qian Shi, Priya U Kumthekar, Sawyer Jacobson, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H Schwartz, Anthony B El-Khoueiry, Jennifer J Knox, Lakshmi Rajdev, Monica M Bertagnolli, Jeffrey A Meyerhardt, Eileen M O'Reilly, Alan P Venook
CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma. Cancer research communications 4 (3) (2024)
Ghassan K Abou-Alfa, Susan M Geyer, Andrew B Nixon, Federico Innocenti, Qian Shi, Priya U Kumthekar, Sawyer Jacobson, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H Schwartz, Anthony B El-Khoueiry, Jennifer J Knox, Lakshmi Rajdev, Monica M Bertagnolli, Jeffrey A Meyerhardt, Eileen M O'Reilly, Alan P Venook
CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma. Cancer research communications 4 (3) (2024)
Spinel Karas, Ron H J Mathijssen, Ron H N van Schaik, Alan Forrest, Timothy Wiltshire, Robert R Bies, Federico Innocenti
Model-Based Prediction of Irinotecan-Induced Grade 4 Neutropenia in Cancer Patients: Influence of Incorporating Germline Genetic Factors in the Model. Clinical pharmacology and therapeutics (2024)
Francesca Battaglin, Fang-Shu Ou, Xueping Qu, Howard S Hochster, Donna Niedzwiecki, Richard M Goldberg, Robert J Mayer, Karam Ashouri, Tyler J Zemla, Charles D Blanke, Alan P Venook, Omar Kabbarah, Heinz-Josef Lenz, Federico Innocenti
HER2 Gene Expression Levels Are Predictive and Prognostic in Patients With Metastatic Colorectal Cancer Enrolled in CALGB/SWOG 80405. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (16) (2024)
Francesca Battaglin, Fang-Shu Ou, Xueping Qu, Howard S Hochster, Donna Niedzwiecki, Richard M Goldberg, Robert J Mayer, Karam Ashouri, Tyler J Zemla, Charles D Blanke, Alan P Venook, Omar Kabbarah, Heinz-Josef Lenz, Federico Innocenti
HER2 Gene Expression Levels Are Predictive and Prognostic in Patients With Metastatic Colorectal Cancer Enrolled in CALGB/SWOG 80405. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (16) (2024)
Ghassan K Abou-Alfa, Susan M Geyer, Andrew B Nixon, Federico Innocenti, Qian Shi, Priya U Kumthekar, Sawyer Jacobson, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H Schwartz, Anthony B El-Khoueiry, Jennifer J Knox, Lakshmi Rajdev, Monica M Bertagnolli, Jeffrey A Meyerhardt, Eileen M O'Reilly, Alan P Venook
CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma. Cancer research communications 4 (3) (2024)
Francesca Battaglin, Fang-Shu Ou, Xueping Qu, Howard S Hochster, Donna Niedzwiecki, Richard M Goldberg, Robert J Mayer, Karam Ashouri, Tyler J Zemla, Charles D Blanke, Alan P Venook, Omar Kabbarah, Heinz-Josef Lenz, Federico Innocenti
HER2 Gene Expression Levels Are Predictive and Prognostic in Patients With Metastatic Colorectal Cancer Enrolled in CALGB/SWOG 80405. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Ghassan K Abou-Alfa, Susan M Geyer, Andrew B Nixon, Federico Innocenti, Qian Shi, Priya U Kumthekar, Sawyer Jacobson, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H Schwartz, Anthony B El-Khoueiry, Jennifer J Knox, Lakshmi Rajdev, Monica M Bertagnolli, Jeffrey A Meyerhardt, Eileen M O'Reilly, Alan P Venook
CCALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C infection in Patients with advanced hepatocellular carcinoma. Cancer research communications (2024)
Ghassan K Abou-Alfa, Susan M Geyer, Andrew B Nixon, Federico Innocenti, Qian Shi, Priya U Kumthekar, Sawyer Jacobson, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H Schwartz, Anthony B El-Khoueiry, Jennifer J Knox, Lakshmi Rajdev, Monica M Bertagnolli, Jeffrey A Meyerhardt, Eileen M O'Reilly, Alan P Venook
CCALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C infection in Patients with advanced hepatocellular carcinoma. Cancer research communications (2024)
Spinel Karas, Ron H J Mathijssen, Ron H N van Schaik, Alan Forrest, Timothy Wiltshire, Robert R Bies, Federico Innocenti
Model-Based Prediction of Irinotecan-Induced Grade 4 Neutropenia in Cancer Patients: Influence of Incorporating Germline Genetic Factors in the Model. Clinical pharmacology and therapeutics 115 (5) (2024)
Francesca Battaglin, Fang-Shu Ou, Federico Innocenti, Heinz-Josef Lenz
Reply to A. Sartore-Bianchi et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Ghassan K Abou-Alfa, Susan M Geyer, Andrew B Nixon, Federico Innocenti, Qian Shi, Priya U Kumthekar, Sawyer Jacobson, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H Schwartz, Anthony B El-Khoueiry, Jennifer J Knox, Lakshmi Rajdev, Monica M Bertagnolli, Jeffrey A Meyerhardt, Eileen M O'Reilly, Alan P Venook
CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma. Cancer research communications 4 (3) (2024)
Ghassan K Abou-Alfa, Susan M Geyer, Andrew B Nixon, Federico Innocenti, Qian Shi, Priya U Kumthekar, Sawyer Jacobson, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H Schwartz, Anthony B El-Khoueiry, Jennifer J Knox, Lakshmi Rajdev, Monica M Bertagnolli, Jeffrey A Meyerhardt, Eileen M O'Reilly, Alan P Venook
CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma. Cancer research communications 4 (3) (2024)
Nancy Gillis, Amy S Etheridge, Sushant A Patil, D Neil Hayes, Michele C Hayward, J Todd Auman, Joel S Parker, Federico Innocenti
Sequencing of genes of drug response in tumor DNA and implications for precision medicine in cancer patients. The pharmacogenomics journal (2023)
Federico Innocenti, Wancen Mu, Xueping Qu, Fang-Shu Ou, Omar Kabbarah, Charles David Blanke, Alan P Venook, Heinz-Josef Lenz, Naim U Rashid
DNA Mutational Profiling in Patients With Colorectal Cancer Treated With Standard of Care Reveals Differences in Outcome and Racial Distribution of Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Kanwal P S Raghav, Fang-Shu Ou, Alan P Venook, Federico Innocenti, Ryan Sun, Heinz-Josef Lenz, Edmund S Kopetz
Acquired Genomic Alterations on First-Line Chemotherapy With Cetuximab in Advanced Colorectal Cancer: Circulating Tumor DNA Analysis of the CALGB/SWOG-80405 Trial (Alliance). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Julia Coelho França Quintanilha, Alessandro Racioppi, Jin Wang, Amy S Etheridge, Stefanie Denning, Carol E Peña, Andrew D Skol, Daniel J Crona, Danyu Lin, Federico Innocenti
PIK3R5 genetic predictors of hypertension induced by VEGF-pathway inhibitors. The pharmacogenomics journal (2021)
Spinel Karas, Federico Innocenti
All You Need to Know About UGT1A1 Genetic Testing for Patients Treated With Irinotecan: A Practitioner-Friendly Guide. JCO oncology practice (2021)
Julia C F Quintanilha, Jin Wang, Alexander B Sibley, Chen Jiang, Amy S Etheridge, Fei Shen, Guanglong Jiang, Flora Mulkey, Jai N Patel, Daniel L Hertz, Elizabeth Claire Dees, Howard L McLeod, Monica Bertagnolli, Hope Rugo, Hedy L Kindler, William Kevin Kelly, Mark J Ratain, Deanna L Kroetz, Kouros Owzar, Bryan P Schneider, Danyu Lin, Federico Innocenti
Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients. British journal of cancer (2021)
Julia C F Quintanilha, Jin Wang, Alexander B Sibley, Chen Jiang, Amy S Etheridge, Fei Shen, Guanglong Jiang, Flora Mulkey, Jai N Patel, Daniel L Hertz, Elizabeth Claire Dees, Howard L McLeod, Monica Bertagnolli, Hope Rugo, Hedy L Kindler, William Kevin Kelly, Mark J Ratain, Deanna L Kroetz, Kouros Owzar, Bryan P Schneider, Danyu Lin, Federico Innocenti
Correction: Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients. British journal of cancer (2021)
Spinel Karas, Amy S Etheridge, Deborah A Nickerson, Nancy J Cox, Karen L Mohlke, Erika Cecchin, Giuseppe Toffoli, Ron H J Mathijssen, Alan Forrest, Robert R Bies, Federico Innocenti
Integration of DNA sequencing with population pharmacokinetics to improve the prediction of irinotecan exposure in cancer patients. British journal of cancer (2021)
Spinel Karas, Amy S Etheridge, Eleftheria Tsakalozou, Jacqueline Ramírez, Erika Cecchin, Ron H N van Schaik, Giuseppe Toffoli, Mark J Ratain, Ron H J Mathijssen, Alan Forrest, Robert R Bies, Federico Innocenti
Optimal Sampling Strategies for Irinotecan (CPT-11) and its Active Metabolite (SN-38) in Cancer Patients. The AAPS journal 22 (3) (2020)
Brendan J Guercio, Sui Zhang, Alan P Venook, Fang-Shu Ou, Donna Niedzwiecki, Heinz-Josef Lenz, Federico Innocenti, Brian C Mullen, Bert H O'Neil, James E Shaw, Blase N Polite, Howard S Hochster, James N Atkins, Richard M Goldberg, Justin C Brown, Eileen M O'Reilly, Robert J Mayer, Charles David Blanke, Charles S Fuchs, Jeffrey A Meyerhardt
Body Mass Index and Weight Loss in Metastatic Colorectal Cancer in CALGB (Alliance)/SWOG 80405. JNCI cancer spectrum 4 (3) (2020)
Brendan J Guercio, Sui Zhang, Fang-Shu Ou, Alan P Venook, Donna Niedzwiecki, Heinz-Josef Lenz, Federico Innocenti, Michael N Pollak, Andrew B Nixon, Brian C Mullen, Bert H O'Neil, James E Shaw, Blase N Polite, Al Bowen Benson, James N Atkins, Richard M Goldberg, Justin C Brown, Eileen M O'Reilly, Robert J Mayer, Charles David Blanke, Charles S Fuchs, Jeffrey A Meyerhardt
IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405. JNCI cancer spectrum 5 (1) (2020)
Federico Innocenti, Kouros Owzar, Chen Jiang, Amy S Etheridge, Raluca Gordân, Alexander B Sibley, Flora Mulkey, Donna Niedzwiecki, Dylan Glubb, Nicole Neel, Mark S Talamonti, David J Bentrem, Eric Seiser, Jen Jen Yeh, Katherine Van Loon, Howard McLeod, Mark J Ratain, Hedy L Kindler, Alan P Venook, Yusuke Nakamura, Michiaki Kubo, Gloria M Petersen, William R Bamlet, Robert R McWilliams
The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation. PloS one 13 (8) (2018)
Federico Innocenti
Bringing a genomic perspective to the safety of drug treatment in oncology. F1000Research 6 (2017)